Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
Mulder, Frits I., Bosch, Floris T.M., Young, Annie M., Marshall, Andrea, McBane, Robert D., Zemla, Tyler J., Carrier, Marc, Kamphuisen, Pieter Willem, Bossuyt, Patrick M.M., Büller, Harry R., Weitz, Jeffrey I., Middeldorp, Saskia, van Es, Nick
Published in Blood (17.09.2020)
Published in Blood (17.09.2020)
Get full text
Journal Article
Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance)
Nakasone, Elizabeth S, Zemla, Tyler J, Yu, Ming, Lin, She Yu, Ou, Fang-Shu, Carter, Kelly, Innocenti, Federico, Saltz, Leonard, Grady, William M, Cohen, Stacey A
Published in Epigenetics (01.12.2024)
Published in Epigenetics (01.12.2024)
Get full text
Journal Article
Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study
Palmer, Mathias E, Gile, Jennifer J, Storandt, Michael H, Jin, Zhaohui, Zemla, Tyler J, Tran, Nguyen H, Mahipal, Amit
Published in Cancers (01.10.2023)
Published in Cancers (01.10.2023)
Get full text
Journal Article
SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma
Martini, Andrea, Prasai, Kritika, Zemla, Tyler J, Ahmed, Fowsiyo Y, Elnagar, Mamoun B, Giama, Nasra H, Guzzardo, Vincenza, Biasiolo, Alessandra, Fassan, Matteo, Yin, Jun, Pontisso, Patrizia, Roberts, Lewis R
Published in Cancers (01.01.2024)
Published in Cancers (01.01.2024)
Get full text
Journal Article
Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma
Storandt, Michael H, Gile, Jennifer J, Palmer, Mathias E, Zemla, Tyler J, Ahn, Daniel H, Bekaii-Saab, Tanios S, Jin, Zhaohui, Tran, Nguyen H, Mahipal, Amit
Published in Cancers (22.10.2022)
Published in Cancers (22.10.2022)
Get full text
Journal Article
Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non–Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711)
Gajra, Ajeet, Zemla, Tyler J., Jatoi, Aminah, Feliciano, Josephine L., Wong, Melisa L., Chen, Hongbin, Maggiore, Ronald, McMurray, Ryan P., Hurria, Arti, Muss, Hyman B., Cohen, Harvey J., Lafky, Jacqueline, Edelman, Martin J., Lilenbaum, Rogerio, Le-Rademacher, Jennifer G.
Published in Journal of thoracic oncology (01.07.2018)
Published in Journal of thoracic oncology (01.07.2018)
Get full text
Journal Article
Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance)
Symonds, Lynn, Yu, Ming, Zhang, YuHong, Ou, Fang-Shu, Zemla, Tyler J., Carter, Kelly, Bertagnolli, Monica, Innocenti, Federico, Bosch, Linda JW, Meijer, Gerrit A, Carvalho, Beatriz, Grady, William M., Cohen, Stacey A.
Published in Epigenetics (02.12.2022)
Published in Epigenetics (02.12.2022)
Get full text
Journal Article
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
Sinicrope, Frank A, Shi, Qian, Hermitte, Fabienne, Zemla, Tyler J, Mlecnik, Bernhard, Benson, Al B, Gill, Sharlene, Goldberg, Richard M, Kahlenberg, Morton S, Nair, Suresh G, Shields, Anthony F, Smyrk, Thomas C, Galon, Jerome, Alberts, Steven R
Published in JNCI cancer spectrum (01.06.2020)
Published in JNCI cancer spectrum (01.06.2020)
Get full text
Journal Article
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome
Innocenti, Federico, Ou, Fang-Shu, Qu, Xueping, Zemla, Tyler J, Niedzwiecki, Donna, Tam, Rachel, Mahajan, Shilpi, Goldberg, Richard M, Bertagnolli, Monica M, Blanke, Charles D, Sanoff, Hanna, Atkins, James, Polite, Blasé, Venook, Alan P, Lenz, Heinz-Josef, Kabbarah, Omar
Published in Journal of clinical oncology (10.05.2019)
Published in Journal of clinical oncology (10.05.2019)
Get full text
Journal Article
Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study
Storandt, Michael H, Zemla, Tyler J, Patell, Kanchi, Naleid, Nikolas, Gile, Jennifer J, Tran, Nguyen H, Chakrabarti, Sakti, Jin, Zhaohui, Borad, Mitesh, Mahipal, Amit
Published in The oncologist (Dayton, Ohio) (09.07.2024)
Published in The oncologist (Dayton, Ohio) (09.07.2024)
Get full text
Journal Article
HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405
Battaglin, Francesca, Ou, Fang-Shu, Qu, Xueping, Hochster, Howard S, Niedzwiecki, Donna, Goldberg, Richard M, Mayer, Robert J, Ashouri, Karam, Zemla, Tyler J, Blanke, Charles D, Venook, Alan P, Kabbarah, Omar, Lenz, Heinz-Josef, Innocenti, Federico
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501)
Snyder, Rebecca A., Zemla, Tyler J., Shi, Qian, Segovia, Diana, Ahmad, Syed A., O’Reilly, Eileen M., Herman, Joseph M., Katz, Matthew H. G.
Published in Annals of surgical oncology (15.07.2024)
Published in Annals of surgical oncology (15.07.2024)
Get full text
Journal Article
Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas
Tchelebi, Leila T., Segovia, Diana, Smith, Koren, Shi, Qian, Fitzgerald, T.J., Chuong, Michael D., Zemla, Tyler J., O'Reilly, Eileen M., Meyerhardt, Jeffrey A, Koay, Eugene J., Lowenstein, Jessica, Shergill, Ardaman, Katz, Matthew H.G., Herman, Joseph M.
Published in International journal of radiation oncology, biology, physics (01.09.2024)
Published in International journal of radiation oncology, biology, physics (01.09.2024)
Get full text
Journal Article
Marine omega‐3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance)
Song, Mingyang, Ou, Fang‐Shu, Zemla, Tyler J., Hull, Mark A., Shi, Qian, Limburg, Paul J., Alberts, Steven R., Sinicrope, Frank A., Giovannucci, Edward L., Van Blarigan, Erin L., Meyerhardt, Jeffrey A., Chan, Andrew T.
Published in International journal of cancer (15.07.2019)
Published in International journal of cancer (15.07.2019)
Get full text
Journal Article
Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931)
Snyder, Rebecca A, He, Jun, Le-Rademacher, Jennifer, Ou, Fang-Shu, Dodge, Andrew B, Zemla, Tyler J, Paskett, Electra D, Chang, George J, Innocenti, Federico, Blanke, Charles, Lenz, Heinz-Josef, Polite, Blasé N, Venook, Alan P
Published in Cancer (15.10.2021)
Published in Cancer (15.10.2021)
Get full text
Journal Article
Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial
Mettu, Niharika B, Ou, Fang-Shu, Zemla, Tyler J, Halfdanarson, Thorvardur R, Lenz, Heinz-Josef, Breakstone, Rimini A, Boland, Patrick M, Crysler, Oxana V, Wu, Christina, Nixon, Andrew B, Bolch, Emily, Niedzwiecki, Donna, Elsing, Alicia, Hurwitz, Herbert I, Fakih, Marwan G, Bekaii-Saab, Tanios
Published in JAMA network open (01.02.2022)
Published in JAMA network open (01.02.2022)
Get full text
Journal Article
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial
Lipsyc-Sharf, Marla, Ou, Fang-Shu, Yurgelun, Matthew B, Rubinson, Douglas A, Schrag, Deborah, Dakhil, Shaker R, Stella, Philip J, Weckstein, Douglas J, Wender, Donald B, Faggen, Meredith, Zemla, Tyler J, Heying, Erica N, Schuetz, Samantha R, Noble, Stephanie, Meyerhardt, Jeffrey A, Bekaii-Saab, Tanios, Fuchs, Charles S, Ng, Kimmie
Published in The oncologist (Dayton, Ohio) (05.04.2022)
Published in The oncologist (Dayton, Ohio) (05.04.2022)
Get full text
Journal Article
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma
Chakrabarti, Sakti, Zemla, Tyler J., Ahn, Daniel H., Ou, Fang‐Shu, Fruth, Briant, Borad, Mitesh J., Hartgers, Mindy L., Wessling, Jaclynn, Walkes, Rachel L., Alberts, Steven R., McWilliams, Robert R., Liu, Minetta C., Durgin, Lori M., Bekaii‐Saab, Tanios S., Mahipal, Amit
Published in The oncologist (Dayton, Ohio) (01.05.2020)
Published in The oncologist (Dayton, Ohio) (01.05.2020)
Get full text
Journal Article
Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial
Jatoi, Aminah, Ou, Fang‐Shu, Ahn, Daniel H., Zemla, Tyler J., Le‐Rademacher, Jennifer G., Boland, Patrick, Ciombor, Kristen K., Jacobs, Nisha L., Pasche, Boris, Cleary, James M., McCune, Jeannine S., Pedersen, Katrina S., Barzi, Afsaneh, Chiorean, E. Gabriela, Heying, Erica N., Lenz, Heinz‐Josef, Sloan, Jeff A., Grothey, Axel, Lacouture, Mario E., Bekaii‐Saab, Tanios
Published in The oncologist (Dayton, Ohio) (01.07.2021)
Published in The oncologist (Dayton, Ohio) (01.07.2021)
Get full text
Journal Article
Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance)
Phipps, Amanda I, Shi, Qian, Zemla, Tyler J, Dotan, Efrat, Gill, Sharlene, Goldberg, Richard M, Hardikar, Sheetal, Jahagirdar, Balkrishna, Limburg, Paul J, Newcomb, Polly A, Shields, Anthony, Sinicrope, Frank A, Sargent, Daniel J, Alberts, Steven R
Published in Cancer epidemiology, biomarkers & prevention (01.06.2018)
Published in Cancer epidemiology, biomarkers & prevention (01.06.2018)
Get full text
Journal Article